HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mai P Hoang Selected Research

Acrospiroma

12/2010Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesis.
8/2010Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas.
4/2009Atypical and malignant hidradenomas: a histological and immunohistochemical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mai P Hoang Research Topics

Disease

35Neoplasms (Cancer)
01/2021 - 04/2002
21Melanoma (Melanoma, Malignant)
01/2021 - 02/2005
11Carcinoma (Carcinomatosis)
01/2020 - 08/2005
8Neoplasm Metastasis (Metastasis)
03/2021 - 09/2002
5Nevus (Nevi)
09/2015 - 10/2003
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 02/2008
4Pigmented Nevus (Melanocytic Nevus)
09/2015 - 02/2005
3Adenocarcinoma
01/2021 - 01/2005
3Inflammation (Inflammations)
08/2018 - 05/2004
3Renal Cell Carcinoma (Grawitz Tumor)
06/2015 - 08/2003
3Acrospiroma
12/2010 - 04/2009
2Merkel Cell Carcinoma
05/2021 - 02/2021
2Granuloma
01/2021 - 02/2013
2Vasculitis (Vasculitides)
01/2018 - 05/2012
2Purpura
01/2018 - 05/2012
2Basal Cell Carcinoma (Rodent Ulcer)
04/2017 - 02/2008
2Thyroid Neoplasms (Thyroid Cancer)
01/2016 - 11/2013
2Hemangioblastoma
12/2014 - 08/2003
2Microcystic adnexal carcinoma
12/2010 - 02/2008
2Epithelioid and Spindle Cell Nevus (Spitz Nevus)
02/2005 - 10/2003
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Neuronal intranuclear inclusion disease
01/2022
1Disease Progression
01/2021
1Neural crest tumor
01/2021
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
10/2019
1Breast Neoplasms (Breast Cancer)
10/2019
1Skin Neoplasms (Skin Cancer)
10/2018
1Systemic Vasculitis
08/2018
1Anetoderma
03/2017
1Follicular Mucinosis
02/2017
1Pharyngitis (Sore Throat)
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2016
1Colorectal Neoplasms (Colorectal Cancer)
01/2016
1Brain Neoplasms (Brain Tumor)
11/2015
1Neuroblastoma
09/2015
1Adenocarcinoma of Lung
06/2015
1Uveal melanoma
02/2015
1Pituitary Neoplasms (Pituitary Adenoma)
06/2014
1Craniopharyngioma (Craniopharyngiomas)
02/2014
1Glioma (Gliomas)
11/2013

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2019 - 02/2003
6Biological ProductsIBA
04/2012 - 04/2002
5Keratins (Keratin)IBA
02/2013 - 06/2004
4MucinsIBA
10/2019 - 01/2002
4ErbB Receptors (EGF Receptor)IBA
10/2012 - 04/2009
4NestinIBA
08/2012 - 05/2010
4Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2007 - 01/2005
3Coloring Agents (Dyes)IBA
04/2017 - 02/2008
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 12/2014
3Monoclonal AntibodiesIBA
06/2014 - 10/2004
3Keratin-5 (Keratin 5)IBA
05/2014 - 03/2006
3Keratin-15 (Keratin 15)IBA
08/2012 - 05/2010
3SynaptophysinIBA
06/2004 - 04/2002
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
02/2021 - 01/2020
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2021
2EpitopesIBA
01/2021 - 04/2015
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2018 - 11/2012
2AcidsIBA
08/2018 - 05/2004
2Immunoglobulin A (IgA)IBA
01/2018 - 05/2012
2RNA (Ribonucleic Acid)IBA
01/2017 - 05/2014
2Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 11/2012
2AntibodiesIBA
04/2015 - 04/2012
2Perilipin-2IBA
02/2014 - 09/2013
2LipidsIBA
09/2013 - 01/2005
2CAM 5.2 antigenIBA
08/2012 - 09/2002
2Keratin-7 (Cytokeratin 7)IBA
08/2012 - 04/2002
2Carcinoembryonic AntigenIBA
08/2012 - 02/2008
2Complement System Proteins (Complement)IBA
01/2012 - 07/2011
2Histones (Histone)IBA
04/2009 - 01/2007
2Mucin-1 (CA 15-3 Antigen)IBA
06/2004 - 02/2003
2Inhibins (Inhibin)IBA
08/2003 - 09/2002
1UbiquitinIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
05/2021
1ClaudinsIBA
03/2021
1Cadherins (E-Cadherin)IBA
03/2021
1beta CateninIBA
03/2021
1SiliconesIBA
01/2021
1AutoantigensIBA
01/2021
1Imiquimod (Aldara)FDA LinkGeneric
01/2021
1AntigensIBA
01/2021
1Pharmaceutical PreparationsIBA
10/2018
1CytokinesIBA
01/2018
1B7-H1 AntigenIBA
09/2017
1Antiphospholipid AntibodiesIBA
03/2017
1Infliximab (Remicade)FDA Link
02/2017
1Combined Antibody TherapeuticsIBA
07/2016
1Neurofibromin 1 (Neurofibromin)IBA
01/2016
1Codon (Codons)IBA
01/2016
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2015
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2015
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
05/2015
1Adrenocorticotropic Hormone (ACTH)FDA Link
06/2014
1TamoxifenFDA LinkGeneric
05/2014
1Androgen Receptors (Androgen Receptor)IBA
02/2014
1Progesterone Receptors (Progesterone Receptor)IBA
02/2014
1CateninsIBA
02/2014
1Estrogen ReceptorsIBA
02/2014

Therapy/Procedure

15Therapeutics
01/2021 - 05/2005
3Immunotherapy
01/2021 - 09/2017
1Combination Drug Therapy (Combination Chemotherapy)
10/2018